| Lightcalls.com |
|
|
![]() |
A classic story that Jonathan Wrigh...A classic story that Jonathan Wright, MD of Kent Wash., likes to acknowledge other doctors at his seminars is to what degree he came upon a "formula" for treating macular degeneration, a condition in the one and the other eyes of deteriorating central vision in the macula lutea (a small yellowish area lying slightly lateral to the retina in the back of the eye) which may lead to blindness. "I discovered a means of stopping macular degeneration - sometimes reversing it - in, of all places, that noted medical journal, called the Yakima (Washington) Valley Sun" he laughingly informs the audience. "The newspaper published the observations of Dr Joseph Bittner onward how he actually reversed his have a title to macular degeneration," he continues. "He reported substantial improvement in his vision following oral doses of selenium and vitamin E Selenium deficiency is endemic [particular and local to the area] in the soils of the state of Washington." In the years that followed, whenever a patient asked Wright if there was an alternative to the allopathic laser treatment, which many times presents hazards, he passed along Bittner's formula. single of his patients had of that kind good results with this regimen that his orthodox ophthalmologist told him that his initial diagnosis of macular degeneration must have been a mistake. Because there is no conventional antidote for this disorder, and quite a scarcely any of Wright's patients showed an improvement, a number of ophthalmologists began to doubt their have initial diagnoses. Wright reported to his audience that several of his patients indicated considerable improvement. A small in number seemed to show a halt in deterioration. Others showed no improvement, or their deterioration continued. However, these rises coupled with that of Bittner, mov Wright to cogitation publications on the subject, and he added other nutrients to the formula@ zinc to accompany he selenium, vitamin E and, eventually, the amino acid, taurine. "My patients appeared to have better results with zinc, vitamin E and taurine added to Dr Bittner's original formula," Wright states. More than 10 years ago, a 61-year aged woman arrived in his office for an cogent appointment with a report of rapidly progressing macular degeneration. She wanted a natural approach to her condition, rather than face the possible hazards of laser treatment. Wright picks up the quiet of the story in a case report he and sum of two units associates prepared for the Journal of Nutritional Medicine: "Her vitamin/mineral appendix record (kept very completely and carefully from her husband) showed she had been taking selenium, vitamin E and zinc in adequate quantities for several years for other reasons. However, she was also known to be hypochlorhydric (short upon hydrochloric acid, the stomach acid essential for efficient digestion of food) allergic and malabsorptive, with equal reason zinc and selenium were given from I.V. (intravenously.) "During the first selenium/zinc. treatment, she holloed for the nurse, reporting that she could read the print upon the poster across the apartment which had been blurred (to her) before the I.V. started. "Following the treatment, she was given I.M. (intramuscular) vitamin E She was advised to continue oral zinc, selenium, and vitamin E in higher doses, and to add taurine. Initially, she stand in want ofed a zinc/selenium boost every sum of two units to three days or her vision would deteriorate again. directly four years later, she still requires a treatment every few weeks. "After this initial succes we subsequently treated a number of cases of macular degeneration with a series of zinc/selenium treatments (along with oral vitamin E and taurine). Oral zinc and selenium supplementation are attract favor toed also. We try to taper not on the medical treatments as before long as is practicable." Wright states that springs have been good since he switched to the initial treatment of zinc/selenium for all patients. Just a single body - initially seen eight years previous - has had no rejoinder to this regimen. Some who have rejoined still need an occasional treatment to augment their oral complements and maintain their visual improvement. This is not at all to allude to however, that most people require as it was invasive supplementation; almost all of us can obtain optimum on a levels of eye nutrients through careful eating and oral nutritional supplements Selenium and zinc appear to be at the heart of prosperous macular degeneration treatment, Wright finishs Vitamin E seems to fulfilment selenium activity, while taurine may or may not be necessary. However, family tests reveal a low to low-normal fasting plasma even of taurine in many patients with macular degeneration. Wright ground no selenium side effects in patients he treated for macular degeneration (although 200 mcg/day should not be exceeded) However, he cautions that long-term zinc supplementation could tip over the copper-zinc ratio, thereby altering the HDL ("good cholesterol) ratio unfavorably, which could possibly cause PVC Can occasional irregular heartbeat) or anemia. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |